Not applicableStudy completedNCT02953951What this trial is testingBlood Transfusions in Coronary Artery Bypass SurgeryWho this might be right forExcessive Amount of Blood / Fluid Transfusion Universita di Verona 95
Testing effectiveness (Phase 2)Ended earlyNCT00840827What this trial is testingEfficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic SyndromesWho this might be right forMyelodysplastic Syndrome Weill Medical College of Cornell University 6
Testing effectiveness (Phase 2)Study completedNCT01980030What this trial is testingUsing ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem CellWho this might be right forPersistent Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Assistance Publique - Hôpitaux de Paris 24
Not applicableApproved For MarketingNCT05937568What this trial is testingExpanded Access for Treatment With ImetelstatWho this might be right forMyelodysplastic Syndromes Geron Corporation
Post-approval studies (Phase 4)Not Yet RecruitingNCT06525948What this trial is testingEfficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAAWho this might be right forAplastic AnemiaTransfusion-dependent Anemia Peking Union Medical College Hospital 54
Post-approval studies (Phase 4)WithdrawnNCT02069886What this trial is testingEffect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent ThalassemiaWho this might be right forThalassemia (Transfusion Delendent) Novartis Pharmaceuticals
Large-scale testing (Phase 3)Not Yet RecruitingNCT07548671What this trial is testingEnarodustat + CsA vs CsA in Newly Diagnosed TD-NSAAWho this might be right forTransfusion-dependent Non-severe Aplastic Anemia Peking Union Medical College Hospital 90
Not applicableStudy completedNCT03660228What this trial is testingPeri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDSWho this might be right forMyelodysplastic Syndromes Dana-Farber Cancer Institute 62
Testing effectiveness (Phase 2)Looking for participantsNCT07096297What this trial is testingLuspatercept + Darbepoetin in MDSWho this might be right forMDS (Myelodysplastic Syndrome) Yale University 60
Post-approval studies (Phase 4)UnknownNCT06299670What this trial is testingEfficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical TrialWho this might be right forTransfusion-dependent Thalassemia Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90
Post-approval studies (Phase 4)Study completedNCT03032666What this trial is testingSofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label TrialWho this might be right forThalassemiaHepatitis C Ala'a Sharara 7
Early research (Phase 1)Ended earlyNCT04925206What this trial is testingA Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-ThalassaemiaWho this might be right forTransfusion Dependent Beta-Thalassaemia EdiGene (GuangZhou) Inc. 8
Not applicableStudy completedNCT05466370What this trial is testingPrediction of Transfusion-Associated ComplicationsWho this might be right forTransfusion-dependent Anemia Kepler University Hospital 3,366
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07558434What this trial is testingCsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAAWho this might be right forSevere Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia Peking Union Medical College Hospital 43
Testing effectiveness (Phase 2)Study completedNCT05355766What this trial is testingLong-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded PatientsWho this might be right forThalassemiaIron Overload Hangzhou Zede Pharma-Tech Co., Ltd. 16
Testing effectiveness (Phase 2)Looking for participantsNCT06280378What this trial is testingΒ-Thalassemia Treatment with KL003 Cell InjectionWho this might be right forTransfusion-dependent Beta-Thalassemia Kanglin Biotechnology (Hangzhou) Co., Ltd. 41
Testing effectiveness (Phase 2)Looking for participantsNCT03653338What this trial is testingT-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other AnemiasWho this might be right forSickle Cell AnemiaBeta-thalassemia MajorDiamond-blackfan Anemia Paul Szabolcs 5
Early research (Phase 1)WithdrawnNCT04176653What this trial is testingStudy in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124Who this might be right forNon-transfusion-dependent ThalassemiaLow Risk Myelodysplastic Syndrome Silence Therapeutics plc
Large-scale testing (Phase 3)Active Not RecruitingNCT03223961What this trial is testingA Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDSWho this might be right forMyelodysplastic Syndromes Groupe Francophone des Myelodysplasies 124
Not applicableUnknownNCT03275051What this trial is testingLong-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)Who this might be right forBeta Thalassaemia IRCCS San Raffaele 9